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HIV/AIDS continues to ravage sub-Saharan Africa, and in
South Africa accounts for 30% of all mortality, making it the
leading cause of death.
1
The epidemic has had other negative
effects, which have not been fully realised.  Among these is the
fact that, paradoxically, the awareness programmes
implemented to prevent major spread of HIV/AIDS have
complicated the prevention of non-communicable diseases
(NCDs).
Among South African women HIV/AIDS is characterised by
severe wasting; therefore many women prefer to maintain a
higher body weight in an effort to overcome this stigma.
Research has shown that being overweight is a risk factor
contributing to disease in developed countries. Policies have
been developed aiming to promote healthier lifestyles, but how
effective can these policies be if there is such a stigma attached
to health behaviour modification in the eyes of black South
African women? The reason awareness programmes are
created is to inform communities of lifestyles aimed at
preventing major diseases. Evidently there is a need to revamp
these programmes taking specific cultural values into
consideration and to encourage overall healthy behaviour.
Until cultural norms are better understood, certain steps need
to be taken with regard to educating countries on healthy
behaviours.
Cultural barriers to adoption of healthy
behaviours
NCDs include inter alia hypertensive heart disease, stroke, and
diabetes. These NCDs and their risk factors are among the top
20 specific causes of premature mortality. In each of these
diseases mortality is higher among females than males.1 In
South Africa, cardiovascular disease alone accounts for 17% of
deaths,1 making it the second-ranked cause of mortality after
HIV/AIDS. However, HIV/AIDS has a different clinical
picture to most NCDs because it is characterised by severe
wasting. Can weight loss or even becoming thin be a sign of
infection and impending death? Women may subscribe to this
view, and therefore prefer to maintain a higher body weight.
This can be lethal because large body size is a powerful risk
factor for many NCDs. 
Overweight is listed by the World Health Organization
(WHO) as one of 10 leading risk factors contributing to the
burden of disease in developed countries, as measured by
disability-adjusted life years (DALYs).2 A recent national survey
reported that more than one-quarter (27%) of black South
African women were overweight and nearly one-third (32%)
were obese.3 Clearly, weight must be brought under control if
the NCD epidemic in South Africa is to be contained.
The WHO has developed a global policy for the integration
of diet and physical activity in the prevention and control of
NCDs.2 The strategy aims to promote healthy lifestyles (food
choices and increased physical activity) in a healthy
environment, and maintenance of recommended body weight.
But how realistic is this policy, given the existing challenges
confronting most impoverished individuals, and the cultural
norms that guide them? Recent research has indicated that
black South African women at risk for NCDs are not adhering
to healthy lifestyle behaviour modification, such as
maintenance of an ideal weight, because of the weight-loss
stigma associated with the HIV/AIDS wasting syndrome.4 The
following quote typifies this: ‘If you are thin, people think that
you are sick — you may have TB or HIV/AIDS.’ Studies have
shown that for black women, being overweight is associated
with high socio-economic status, attractiveness, happiness and
good health.5
As an example of how successful HIV/AIDS prevention
education has been with youth, consider the answers children
gave when asked in a focus group discussion ‘What should one
do to keep healthy?’. The most common responses were to use
condoms, have one faithful partner, or abstain from sex.6
Meanwhile there have been very limited strategies to prevent
NCDs. Fortunately, younger women are becoming more
conscious of their body size because of media influence and
acculturation.7
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Promotion of culturally relevant
educational messages needed
Comprehensive educational messages are warranted so that
communities can adopt lifestyles that prevent the major disease
burdens, without having to focus on a specific condition. The
educational messages recommended for most NCDs are the
same: follow the correct diet, be physically active, decrease
stress levels, visit a doctor regularly, and screen for the
prevention and early detection of disease. However, we have to
modify these efforts taking cultural attitudes into account.
Weight loss should not be stressed specifically (especially in
sub-Saharan Africa); instead overall healthy behaviours should
be encouraged. Many NCDs are socially and culturally rooted;
until cultural norms related to overnutrition are better
understood, emphasis should be placed on eating more
nutritious food such as fresh fruits and vegetables, decreasing
salt and sugar intake, and increasing physical activity for
energy expenditure. In addition, existing beliefs about body
image need to be revised, using effective strategies. This will
only be possible with a heightened awareness and public
health mandate for curbing the growing epidemic of NCDs
and the risk factor of obesity that fuels it.
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The Medicines Control Council alerts all health care
professionals to new safety information regarding the
increased risk of hyperglycaemia and diabetes mellitus in
patients treated with the atypical antipsychotic medicines,
clozapine, olanzepine, quetiapine, risperidone and
ziprasidone.
Epidemiological studies have identified an increased risk of
treatment-emergent metabolic adverse events associated with
the atypical antipsychotic medicines. Lipid abnormalities and
weight gain are frequently occurring adverse effects
associated with the atypical antipsychotics. Abnormalities in
glucose metabolism range from hyperglycaemia in patients
with or without previously known diabetes mellitus to cases
of ketoacidosis, hyperosmolar coma and death. 
The background risk of type 2 diabetes mellitus in
schizophrenic patients as well as the increasing incidence of
diabetes mellitus in the general population may be
confounders. Patients with existing diabetes in whom
antipsychotic therapy is initiated should be closely monitored
for worsening of diabetic control.
All patients treated with atypical antipsychotic medicines
should be monitored for symptoms of hyperglycaemia.
Fasting blood glucose testing should be done on all patients
who develop symptoms of hyperglycaemia, or who are at risk
for type 2 diabetes. 
In some cases, hyperglycaemia resolved after
discontinuation of the atypical antipsychotic medicine;
however, there have been cases in which it has persisted
despite stopping therapy, requiring the prescription of anti-
diabetic medication.
Please continue reporting all adverse drug reactions
associated with atypical antipsychotic medicines and other
medicines to the National Adverse Drug Event Monitoring
Centre, tel. (021) 447-1618, fax (021) 448-6181.
Medicines Control Council
Cape Town
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